Maa: Israel
Kieli: englanti
Lähde: Ministry of Health
EZETIMIBE
NOVARTIS ISRAEL LTD
C10AX09
TABLETS
EZETIMIBE 10 MG
PER OS
Required
LEK PHARMACEUTICALS D.D., SLOVENIA
EZETIMIBE
Primary hypercholesterolemia: Ezetimibe Sandoz administered with an HMG-CoA reductase inhibitor (statin) or alone are indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familial and non-familial) hypercholesterolemia. Homozygous familial hypercholesterolemia (HoFH): Ezetimibe Sandoz administered with a statin are indicated for use in patients with HoFH.Patients may also receive adjunctive treatments (e.g. LDL apheresis).Homozygous sitosterolemia (Phytosterolemia): Ezetimibe Sandoz are indicated for use in patients with homozygous familial sitosterolemia.
2019-07-09
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS (PREPARATIONS) - 1986 THIS MEDICINE IS TO BE SUPPLIED UNDER DOCTOR’S PRESCRIPTION ONLY EZETIMIBE SANDOZ ® TABLETS ACTIVE SUBSTANCE AND ITS AMOUNT: Each tablet contains: ezetimibe 10 mg For a list of inactive ingredients please refer to ‘Important information about some of the ingredients of Ezetimibe Sandoz’ as well as section 6. READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THIS MEDICINE. • This leaflet contains concise information about Ezetimibe Sandoz. If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their ailment seems similar to yours. 1. WHAT IS EZETIMIBE SANDOZ USED FOR? Ezetimibe Sandoz is intended for patients with: Primary hypercholesterolemia: Ezetimibe Sandoz administered with an HMG CoA reductase inhibitor (statin) or alone are indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familial and non familial) hypercholesterolemia. Homozygous familial hypercholesterolemia (HoFH): Ezetimibe Sandoz administered with a statin are indicated for use in patients with HoFH. Patients may also receive adjunctive treatments (e.g. LDL apheresis). Homozygous sitosterolemia (Phytosterolemia): Ezetimibe Sandoz is indicated for use in patients with homozygous familial sitosterolemia. THERAPEUTIC GROUP: Ezetimibe is a member of a class of medicines called _ CAI _ (Cholesterol Absorption Inhibitors), which inhibits the intestinal absorption of cholesterol. 2. BEFORE YOU TAKE EZETIMIBE SANDOZ DO NOT TAKE EZETIMIBE SANDOZ: • if you are allergic (hypersensitive) to ezetimibe or any of the other ingredients of Ezetimibe Sandoz (see also section 6). • together with a statin, if you currently have liver problems. • together with a statin, if you are pregnant or breast feeding. If you use Ezetimibe Sandoz together with a statin, please read the package leaflet of that particular medicine. If you Lue koko asiakirja